4559 ZERIA PHARMACEUTICAL CO.,LTD.ゼリア新薬工業TSE Prime / Pharmaceuticals
0 posts
ZERIA PHARMACEUTICAL CO.,LTD. (4559) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
ZERIA PHARMACEUTICAL CO.,LTD. (4559) Stock Price History
ZERIA PHARMACEUTICAL CO.,LTD. closed at ¥2,068 on Nov 20, 2026, +2.4% over 1 month, +5.9% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥102,427 today (+2.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved +2.4%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥2,068 | −27 | −1.29% |
| Nov 19 (Thu) | ¥2,095 | +18 | +0.87% |
| Nov 18 (Wed) | ¥2,077 | −23 | −1.10% |
| Nov 17 (Tue) | ¥2,100 | −11 | −0.52% |
| Nov 16 (Mon) | ¥2,111 | +23 | +1.10% |
| Nov 13 (Fri) | ¥2,088 | +4 | +0.19% |
| Nov 12 (Thu) | ¥2,084 | +39 | +1.91% |
| Nov 11 (Wed) | ¥2,045 | −24 | −1.16% |
| Nov 10 (Tue) | ¥2,069 | +6 | +0.29% |
| Nov 9 (Mon) | ¥2,063 | +42 | +2.08% |
If you had invested ¥100,000 3 months ago, it would be worth ¥96,186 today (−3.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −3.8%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥2,068 | −27 | −1.29% |
| Nov 19 (Thu) | ¥2,095 | +18 | +0.87% |
| Nov 18 (Wed) | ¥2,077 | −23 | −1.10% |
| Nov 17 (Tue) | ¥2,100 | −11 | −0.52% |
| Nov 16 (Mon) | ¥2,111 | +23 | +1.10% |
| Nov 13 (Fri) | ¥2,088 | +4 | +0.19% |
| Nov 12 (Thu) | ¥2,084 | +39 | +1.91% |
| Nov 11 (Wed) | ¥2,045 | −24 | −1.16% |
| Nov 10 (Tue) | ¥2,069 | +6 | +0.29% |
| Nov 9 (Mon) | ¥2,063 | +42 | +2.08% |
If you had invested ¥100,000 6 months ago, it would be worth ¥86,927 today (−13.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −13.1%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥2,068 | +4.6% |
| Oct 2026 | ¥1,977 | +0.8% |
| Sep 2026 | ¥1,962 | −2.9% |
| Aug 2026 | ¥2,021 | −3.3% |
| Jul 2026 | ¥2,090 | +2.4% |
| Jun 2026 | ¥2,041 | −11.0% |
| May 2026 | ¥2,292 | +6.2% |
If you had invested ¥100,000 1 year ago, it would be worth ¥105,888 today (+5.9%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved +5.9%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥2,068 | +4.6% |
| Oct 2026 | ¥1,977 | +0.8% |
| Sep 2026 | ¥1,962 | −2.9% |
| Aug 2026 | ¥2,021 | −3.3% |
| Jul 2026 | ¥2,090 | +2.4% |
| Jun 2026 | ¥2,041 | −11.0% |
| May 2026 | ¥2,292 | +6.2% |
| Apr 2026 | ¥2,159 | −1.6% |
| Mar 2026 | ¥2,195 | −2.6% |
| Feb 2026 | ¥2,253 | +9.7% |
| Jan 2026 | ¥2,054 | −2.1% |
| Dec 2025 | ¥2,099 | +2.2% |
| Nov 2025 | ¥2,054 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥104,709 today (+4.7%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved +4.7%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥2,068 | −1.5% |
| 2025 | ¥2,099 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥104,024 today (+4.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved +4.0%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥2,068 | −1.5% |
| 2025 | ¥2,099 | ― |
If you had invested ¥100,000 in Jan 2001, it would be worth ¥204,018 today (+104.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +334.1%, while this stock moved +104.0%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥2,068 | −1.5% |
| 2025 | ¥2,099 | −14.0% |
| 2024 | ¥2,442 | +21.1% |
| 2023 | ¥2,017 | −10.9% |
| 2022 | ¥2,263 | +15.1% |
| 2021 | ¥1,966 | +3.4% |
| 2020 | ¥1,901 | −9.6% |
| 2019 | ¥2,104 | +6.6% |
| 2018 | ¥1,973 | −8.5% |
| 2017 | ¥2,156 | +19.5% |
| 2016 | ¥1,804 | +12.0% |
| 2015 | ¥1,610 | −20.1% |
| 2014 | ¥2,014 | −21.5% |
| 2013 | ¥2,565 | +97.2% |
| 2012 | ¥1,301 | +7.7% |
| 2011 | ¥1,208 | +34.4% |
| 2010 | ¥899 | +15.9% |
| 2009 | ¥775 | −17.6% |
| 2008 | ¥941 | +4.5% |
| 2007 | ¥900 | −8.2% |
| 2006 | ¥980 | −2.9% |
| 2005 | ¥1,009 | +1.8% |
| 2004 | ¥991 | −1.1% |
| 2003 | ¥1,002 | +20.4% |
| 2002 | ¥832 | −15.3% |
| 2001 | ¥982 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jan 2001). Please check the latest prices before trading.
ZERIA PHARMACEUTICAL CO.,LTD. (4559) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of ZERIA PHARMACEUTICAL CO.,LTD. (4559)
Business overview
Together with 19 subsidiaries and one affiliate, the company runs prescription drug, consumer healthcare and other businesses. In prescription drugs, the company makes, buys and sells prescription drugs, while Tillotts Pharma AG overseas and its subsidiaries and others make and sell prescription drugs. Subsidiary 「ゼリアップ」 takes on sales promotion of the company's prescription drugs. In consumer healthcare, the company makes, buys and sells OTC drugs and health foods for self-medication, 「ゼリアヘルスウエイ」 sells health foods and more, and 「イオナ インターナショナル」 makes and sells cosmetics. Other businesses include insurance agency and real estate.
Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| Dividend yield | 2.47% | No. 28 in the sector (highest first); median 2.97% |
|---|---|---|
| PER | 9.1x | Below the sector median of 16.5x (No. 5 from the lowest) |
| PBR | 0.82x | Below the sector median of 1.86x (No. 11 from the lowest) |
| ROE | 9.00% | No. 16 in the sector (highest first); median 4.17% |
| Market cap | ¥91.2 bn | No. 24 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥2,400 | 5/25 |
|---|---|---|
| 52-week low | ¥1,898 | 10/2 |
| Current position | 33.9% | Where the low is 0% and the high is 100% (close on 11/20: ¥2,068) |
| Year to date | -1.5% | No. 20 of 77 in the sector (best first) |
| 1 year | +5.9% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 gainers | 1 times | Latest: 11/5 (No. 37) |
|---|
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/16 18:30(訂正)「当社連結子会社によるHaupt Pharma Wulfling GmbHの持分取得(孫会社化)に関するお知らせ」及び「2027年3月期 中間期決算短信」の一部訂正について
- 11/04 16:00期末配当予想の修正(増配)に関するお知らせ
- 11/04 16:002027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)
- 10/26 08:30当社連結子会社によるHaupt Pharma Wulfling GmbHの持分取得(孫会社化)に関するお知らせ
Filings from the past 12 months (4).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the ZERIA PHARMACEUTICAL CO.,LTD. board
More Japanese stocks in English
- Value Soft Holdings Corporation455A
- AnGes,Inc.4563
- OncoTherapy Science,Inc.4564
- Nxera Pharma Co.,Ltd.4565
- KYORIN Pharmaceutical Co.,Ltd.4569
- HUMAN MADE Inc.456A
- Immuno-Biological Laboratories Co.,Ltd.4570
- Nano Holdings,Inc.4571
- Carna Biosciences,Inc.4572
- TAIKO PHARMACEUTICAL CO.,LTD.4574
- CanBas Co.,Ltd.4575
- D.Western Therapeutics Institute, Inc.4576